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Abstract 
Ibogaine  is  claimed  to  be an effective  treatment  for  opiate  and stimulant  addiction.  O’Heam  and Molliver,  however,  showed that 
ibogaine causes degeneration of cerebellar Purkinje  cells in rats. The present study re-examined cerebellar responses to the high doses of 
ibogaine used by O’Hearn  and Molliver  (100 mg/kg  or 3 X  100 mg/kg)  and sought to determine whether a lower  dose (40 mg/kg),  one 
effective in reducing morphine and cocaine self-administration,  produced similar  responses. Purkinje  cell degeneration was evaluated  with 
~8  Fink-Heimer  II  stain, and enhanced glial  cell activity  with  an antibody  to glial  fibrillary  acidic  protein.  Every  rat treated with  the high 
I  ,e of  ibogaine displayed clear evidence of  Purkinje  cell  degeneration. The degeneration consistently  occurred  in the intermediate and 
lateral cerebellum, as well  as the vermis.  Purkinje cells in lobules 5 and 6 were particularly  susceptible. Given  the response properties of 
cells in these lobules, this finding  suggests any long-term  motor deficits  produced by ibogaine-induced  degeneration should preferentially 
affect the head and upper extremity.  In marked contrast, rats given the smaller dose of ibogaine displayed  no degeneration above the level 
seen in  saline-treated animals.  When  combined  with  information  on  other  compounds,  these data  suggest that  the  degenerative and 
‘anti-addictive’  properties of  ibogaine reflect  different  actions of  the drug. 
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1. Introduction 
Two  United  States  patents  (H.  Lotsof,  1985,  No. 
4,499,096;  H.  Lotsof,  1986, No.  4,587,243)  claim  that 
ibogaine can be used as an effective  treatment for  human 
opioid  (heroin)  and stimulant  (amphetamine and cocaine) 
tdiction. Many  experimental studies in animals lend sup- 
port to this claim.  In rats, for  instance, ibogaine decreased 
self-administration of both morphine [IO] and cocaine [2,9]. 
These studies further showed that ibogaine has long-acting 
effects: the decreased self-administration  lasted 24 h, and 
Sometimes longer. following  a single intraperitoneal treat- 
ment with  40 mg/kg  ibogaine [2,10]. 
Despite these promising experimental results, studies by 
‘Hearn et al. and O’Hearn  and Molliver  [19,20] suggest 
that ibogaine may be toxic  to some parts of  the brain.  In 
particular,  these studies demonstrated that, in the rat, ibo- 
gaine produces degeneration of  cerebellar  Purkinje  cells. 
Furthermore, ablation of the inferior olive,  the source of all 
climbing  fiber  inputs to Purkinje  cells, appeared to elimi- 
nate  the  ibogaine-induced  degeneration  [2l].  This  led 
O’Hearn  and  Molliver  to  propose that  the  degeneration 
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results  from  overexcitation  of  the  inferior  olive  that,  in 
turn,  causes excitotoxicity  in  Purkinje  cells. 
A  number of important  issues regarding ibogaine toxic- 
ity  remain  unresolved.  First,  to  produce  degeneration of 
cerebellar  Purkinje  cells,  O’Hearn  and Molliver  gave rats 
one to three injections of  100 mg/kg  ibogaine. Such doses 
are at  least 2.5  times  higher  than  those that  can reduce 
morphine  and  cocaine  self-administration  [2, lo].  Thus, 
these  studies  did  not  address  the  question  of  whether 
degeneration is a natural consequence, or possibly  even a 
requirement  [23],  for  the anti-addictive  properties of  ibo- 
gaine. The present study  sought to determine whether the 
lower  dose  of  ibogaine  used  in  the  self-administration 
studies, 40  mg/kg,  might  cause Purkinje  cell  degenera- 
tion. 
Second, O’Hearn  and Molliver  described the ibogaine- 
induced  degeneration as  occurring  in  longitudinally  ori- 
ented,  parasagittal  strips  in  the  cerebellar  vermis.  This 
pattern  resembles  that  of  the  compartmentation  of  the 
cerebellum revealed through expression of Zebrin antigens 
[ 131. These authors did  not,  however,  determine whether 
specific  groups of  Purkinje  cells  preferentially  respond to 
ibogaine.  Such information  could  be  useful  in  designing 
methods of  evaluating  ibogaine  toxicity  because it  might 
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predict  what motor  deficits  would  most likely  result from 
ibogaine-induced degeneration. 
Finally,  O’Callaghan  et  al.  [IS],  who  measured as- 
trogliosis  with  an ELISA  technique, claim  that  long-term 
exposure to ibogaine ( 14 days) produces markedly  differ- 
ent toxic  responses  in male and female rats. The studies by 
O’Heam  and Molhver,  which examined shorter-term expo- 
sure to  ibogaine,  used only  male rats. The  present study 
sought  to  determine  whether  ibogaine  produces Purkinje 
cell  degeneration  in  female  rats  with  similar  short-term 
exposures.  Because differences  in  drug  sensitivity  (and 
even  anatomical  connectivity)  among  animals  purchased 
from  different  suppliers  have been reported [3,11,14],  the 
present study  also  sought  to  determine  whether  ibogaine 
produces the same toxic  response in Sprague-Dawley  rats 
obtained from  two  different  suppliers. 
Two  approaches were  used to  evaluate cerebellar  re- 
sponses to ibogaine. First, degeneration of cerebellar Purk- 
inje cells was assessed  with  the Fink-Heimer  II  silver stain 
[7].  This  stain  selectively  impregnates degenerating neu- 
ronal  elements (as reviewed  in  [5]).  Although  it  is  used 
primarily  to identify  degenerating axons and terminals [5], 
it  also  readily  identifies  degenerating Purkinje  cell  den- 
drites  [6].  Second,  glial  cell  activation  was  assessed  by 
staining  with  an antibody  to  glial  fibrillary  acidic  protein 
(GFAP).  Glial  cell  activation  usually  accompanies neu- 
ronal  injury  [19];  conceivably  it  could  indicate  a response 
to ibogaine that does not ultimately  lead to overt neuronal 
degeneration. Finally,  to investigate what groups of Purk- 
inje  cells  were  most  susceptible to  ibogaine,  a Zebrin  II 
antibody  [ 131 was  used. Portions  of  this  data have been 
presented in preliminary  form  [17]. 
2. Materials  and  methods 
Data  were collected  from  36  female  Sprague-Dawley 
rats (250-275  g),  16 purchased from  Charles River  and 20 
from  Taconic  Farms. Experimental  animals received intra- 
peritoneal  injections  of  ibogaine hydrochloride  (Sigma  or 
RBI)  dissolved  10 mg/ml  in  water.  Each  received  ibo- 
gaine in either: (1) a single dose of 40 mg/kg;  (2) a single 
dose of  100 mg/kg;  or  (3)  three doses, one per day for 
three  consecutive  days,  of  100 mg/kg.  Control  animals 
received  either  no  injections  or  a  single  intraperitoneal 
injection  of 4 ml/kg  saline. 
The animals were sacrificed with an overdose of sodium 
pentobarbital  7, 21, or  26 days after the final  drug injec- 
tion. They were perfused transcardially with  100 USP units 
of  sodium heparin, saline (containing  10% sodium nitrite) 
and  1000 ml  of  fixative.  The  fixative  consisted of  either 
10% formalin  or a combination  of paraformaldehyde (1% 
to 4%)  and glutaraldehyde  (0%  to  1.25%) in  buffer.  The 
formalin  fixative  proved to be optimal for the Fink-Heimer 
processing. A  mixed  aldehyde fixative  was necessary for 
the immunocytochemical  procedures. 
The brains were removed from  the skull  and cry+pro_ 
tected in sucrose. The cerebella were then separatecj  r..on, 
the brainstem and cut,  with  a freezing  microtome,  I:  30 
km-thick,  coronal sections. All  sections were  saved and 
collected in sets of five.  One section from  each set of five 
was stained with Cresyl violet to allow  identification  of the 
posterior end of the deep cerebellar nuclei. 
Staining  for  degeneration followed  the  second Fink- 
Heimer procedure [7]. Tissue was, selected for  processing 
by  using the set of  five  sections containing  the pokl:“ior 
end of  the  deep cerebellar nuclei  as  a  reference  l~\lint. 
From  this  point,  sections 900  p.m apart (i.e.  from  every 
sixth  set of  five)  were chosen until  the  entire  anterior- 
posterior extent of the cerebellum was sampled. This selec- 
tion  procedure insured that in  every  animal  all  cerebellar 
lobules were systematically evaluated. 
The  Fink-Heimer  stain  can  be  capricious.  Therefore, 
sections  from  one  of  the  first  two  animals  exau  ed 
(animal  Ib2)  were used as controls  for  all  Fink-Hemmer 
staining; in  this  animal tissue preservation was ideal  and 
the cerebellum clearly  contained degeneration. These con- 
trol  sections were processed along with  all  other tissue. If 
degeneration was not apparent in the control  sections, the 
Fink-Heimer  procedure was  repeated on  another  set of 
sections. 
Immunocytochemical staining largely followed  O’)!  ,n 
et  al.  [ 191 for  GFAP  and  Gravel  and  Hawkes  1121  for 
Zebrin. A mouse monoclonal GFAP antibody (Sigma) was 
diluted  1:20000; the anti-Zebrin  II  antibody  (kindly  pro- 
vided  by  Dr.  R.  Hawkes)  was diluted  1:250. Both  were 
revealed with  a Vectastain ABC  kit  and diaminobenzidine. 
One  section  from  each set of  five  was  processed with 
antibody,  producing  staining  in  sections  150  pm  apart, 
which  sampled the entire anterior-posterior  extent 01‘  e 
cerebellum. 
To determine the distribution  of  responses to ibogaine, 
sections from  the cerebellum were projected at a magnifi- 
cation of 23 X  onto a sheet of paper. For each section, the 
edge of  the section, the Purkinje  cell  layer,  and the loca- 
tions of either degeneration  (Fink-Heimer  stained tissue) or 
of  enhanced GFAP  staining  (GFAP-stained  tissue)  were 
drawn. The sections were then examined at  100 X  witi  J 
light  microscope. Any  missed responses to ibogaine were 
manually  added using  tissue landmarks  to  insure  proper 
placement. 
3. Results 
3.1. Identification  of ibogaine response in cerebellum 
Desclin  [6]  noted  that  Purkinje  cell  degeneration  in 
Fink-Heimer  stained, coronal sections appears as rows  of 
coarse silver  granules that  follow  the  orientation  of  the 
Purkinje cell dendrites. The rows extend from  the Purkinje 
cell layer through the molecular cell layer to the surface of t-pro- 
from 
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.g. I.  Fink-Heimer  stained  tissue from  an animal  treated with  3X  100 
mg/kg  ibogaine (A)  and an animal  treated with  40 mg/kg  ibogaine (B). 
Sections are oriented  with  the  granule  cell  layer  (dark)  on  top  and the 
molecular  cell  layer  (light)  below.  In  B,  the  Purkinje  cell  layer  can be 
seen as a single  row  of  black  Purkinje  cell  bodies between the granule 
and molecular cell  layers, In both micrographs, degenerating Purkinje  cell 
dendrites (arrowheads)  appear as longitudinally  oriented  rows  of  silver 
grains that extend across the molecular  cell  layer. The bar represents 100 
II m and applies to A  and B. 
the cerebellum. In  the present study, the staining  patterns 
in animals allowed  to survive  seven days occurred in  two 
forms: (1) bands of granules of varying thickness (Fig.  1A) 
that appeared to represent groups of degenerating Purkinje 
cells;  and (2)  isolated  single  lines  of  granules (Fig.  1B) 
‘“‘it  appeared to represent either single degenerating Purk- 
II!J~ cells  or  artifactual  staining.  It  was  not  possible  to 
differentiate between the latter two possibilities. Therefore, 
the isolated lines  were conservatively  classified  as single 
degenerating Purkinje  cells. 
Over  time,  degenerating,  silver-stained  neurons  are 
phagocytosed [ 1.51.  Thus,  in  animals  with  the longer  sur- 
vival  times, degeneration appeared much less often than in 
l‘irnals  allowed  to  survive  seven days. Furthermore,  de- 
generation found at longer survival  times occurred only  in 
those locations where the greatest amounts of degeneration 
occurred  at  the  shorter  survival  time.  No  new  areas of 
staining were revealed. As a result, the presentation below 
is limited  solely  to data from  animals allowed  to  survive 
seven days. 
In  GFAP-stained  sections, responses to  ibogaine  con- 
sisted of areas of intense staining with  the same locations, 
orientation, and width  as the bands and lines  in  the Fink- 
Heimer stained tissue. Therefore, the intense GFAP-stained 
areas were also classified  as indicating  responses to  ibo- 
gaine  either  by  groups  of  Purkinje  cells  or  by  single 
isolated Purkinje cells. 
3.2. Response  to high doses of ibogaine 
Every  animal treated with  either one or  three doses of 
100 mg/kg  ibogaine and allowed  to  survive  seven days 
displayed  clear  evidence  of  Purkinje  cell  degeneration. 
Characteristically the degeneration occurred in bands simi- 
lar  to  the  one  shown  in  Fig.  1A.  Fig.  2  illustrates  the 
distribution of degeneration in two different  animals treated 
with  3 X 100 mg/kg  ibogaine. For both animals, the sec- 
tions  shown sample all  of  the cerebellar lobules:  the top 
section illustrates the posterior lobe of the cerebellum; the 
middle section, the region where the deep cerebellar nuclei 
are most developed; and the bottom  section, primarily  the 
anterior lobe. Because tissue from  animal Ib2 (Fig.  2, left) 
was used as a degeneration control,  Fink-Heimer  process- 
ing was carried out for  every section from  the cerebellum 
of this animal. Examination of sections from  the rest of the 
cerebellum from  animal Ib2 showed that Fig.  2 presents a 
representative  picture of the ibogaine-induced degeneration 
in this animal, in that no significant  new areas of  staining 
occurred in other sections. 
From Fig.  2 it  is apparent that there was considerable 
animal-to-animal variability  in the amount of degeneration. 
Thus,  it  appears that  the  response to  ibogaine  was  not 
stereotyped. Nevertheless, the patterns of  degeneration in 
the two animals shown in Fig. 2 displayed several common 
features. First, in the bottom two sections for  each animal, 
the degeneration formed  continuous  bands that  extended 
through multiple  lobules  (arrows).  Second, the degenera- 
tion displayed a high degree of bilateral symmetry.  In fact, 
the apparent lack  of  symmetry  in  some sections (i.e.  the 
top  two  of  Fig.  2)  probably  reflects  the  fact  that  the 
sections themselves could not always be cut symmetrically 
due to the curvature of the cerebellum. Third,  some lobules 
appeared more susceptible to the effects  of  ibogaine than 
others. 
To  determine whether the lobule-specific  susceptibility 
suggested by  Fig.  2 holds in  general, the degeneration in 
all  animals  treated  with  3 X  100  mg/kg  ibogaine  and 
allowed  to survive  7 days was quantified.  This  was done 
by classifying  each lobule as containing degeneration if,  in 
a single section, it contained either a  band  of  degeneration 
or  a minimum  of  two  isolated  lines  of  degeneration (as Fig.  2. The distribution  of  degeneration in  three Fink-Heimer-stained  sections  from  two  different  animals  (Ib2  and Ib21)  treated with  3 x  100 mg/kg 
ibogaine.  For both animals,  the right  edge of  the cerebellum  was removed prior  to sectioning  in  order to allow  orientation of  the sections, Dashed lines 
indicate  the location  of  the Purkinje  cell  layer;  solid  black  bars oriented  perpendicular  to the dashed lines indicate the locations of  degenerating Purkinje 
cell  dendrites.  The  arrows  indicate  two  bilaterally  symmetric  bands of  degeneration.  Cerebellar  lobules  are labeled by  numbers  1 through  10 and the 
abbreviations cl  (crus  11,  c2 (crus 21, cop (copulal,  pm (paramedian),  and sim (simplex);  the deep cerebellar nuclei  are labeled dn. 
discussed below, the minimum  of two allowed  differentia- 
tion  between normally  occurring  and unusual amounts of 
degeneration). Fig. 3 presents the results from  10 animals. 
100 
0 
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Lobule 
Fig.  3. The  distribution  of  degeneration across cerebellar  lobules  in  all 
animals treated with  3 X  100 mg/kg  ibogaine. Data were collected  from  6 
Charles  River  animals  (diagonal  shading)  and 4 Taconic  Farms animals 
(cross hatching).  C  ere e  ?r  o  u es are identified  as in Fig.  2.  b  II,  I  b  I 
This  figure  shows that in virtually  every animal degenera- 
tion occurred in four lobules, 5, 6, 7 and simplex (sim)  ‘)a 
the other  hand, in  no  animals did  degeneration occur in 
lobules  1, 2,  9,  and  10. Although  the  sample  size was 
smaller,  a  similar  pattern  occurred  in  animals  given  a 
single dose of  100 mg/kg  ibogaine. This suggests that the 
size of  the dose has more influence  than the number of 
doses in determining  toxicity. 
Fig.  3 also shows that the distribution  of  degeneration 
varied little  across animats obtained from  different  sup“  - 
ers. Thus, although  the amount of degeneration may  vary 
considerably  from  animal  to  animal,  the  source  of  the 
animal appeared to have no significant impact. 
Examination  of  Fig.  3  also reveals that  degeneration 
consistently  occurred in lateral portions of  the cerebellum. 
That  is,  the laterally  placed simplex  lobule  contained de- 
generation in every animal; the crus 2 (~2) and paramedian mdkg 
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(pm)  lobules contained degeneration in at least half of  the 
animals. Thus responses to ibogaine were not confined  to 
the  vermis  (the  medial  portion)  of  the  cerebellum,  as 
suggested by  O’Hearn  et  al.  and O’Heam  and Molliver 
[19,20].  In  addition,  comparison  of  GFAP  and  Zebrin 
staining  patterns indicated  that  responses to  ibogaine  in 
hules  5 and  6 routinely  extended  laterally  out of the 
vermis  and into  pars intermedia (as defined by  Voogd  et 
al. [241). 
As  noted earlier,  GFAP  staining revealed responses to 
ibogaine very similar  to those demonstrated  with  the Fink- 
Heimer  procedure. In  particular,  GFAP  staining occurred 
in  parasagittal  bands  like  those  shown  in  Fig.  2.  The 
Zebrin  antibody  also  revealed parasagittal bands. As  de- 
,ribed previously  [13],  Zebrin  bands in  the anterior lobe 
extended continuously  from  lobule  6  into  lobule  1.  In 
lb 
contrast, GFAP  bands in  the same animals  extended only 
into lobule 3. Thus, there is no one-to-one correspondence 
between Purkinje  cells that contain the Zebrin  antigen and 
those susceptible to ibogaine. 
3.3. Response to a low dose of ibogaine 
According  to Desclin  [6], isolated lines of  Fink-Heimer 
staining, such as in Fig.  lB,  occur sporadically  in normal, 
untreated animals. As can be seen from  Fig. 4, the present 
study confirmed  this observation: in the saline-treated ani- 
mal  (Ibl  1, left),  only  four  isolated  lines  of  silver  grains 
occurred  in  the  13 lobules  shown.  Similar  isolated  lines 
also occurred in  animals treated with  40 mg/kg  ibogaine; 
the sections from  animal Ib14 shown on the right  of Fig. 
contained only  five  isolated lines  in  the same number of 
lb1 
big.  4.  The  distribution  of  degeneration  in  an  animal  treated  with  saline  (Ibl  I)  and  an  animal  treated  with  40  mg/kg  ibogaine  (Ib14).  Sections  were 
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lobules. Most  importantly,  the bands of degeneration (Fig. 
IA)  readily  found  in  animals  treated with  high  doses of 
ibogaine  were never encountered in  animals treated with 
either saline or a low dose of  ibogaine. 
The difference between animals treated with  40 mg/kg 
vs. 3 X  100 mg/kg  ibogaine can readily be appreciated by 
comparing  Figs.  2  and 4.  In  order  to  allow  comparison 
across all  animals, it  would  have been desirable to obtain 
some quantitative measure  of the proportion of the cerebel- 
lum  showing degeneration in each animal. Because of  the 
curvature  and convolutions  of  the cerebellar cortex,  it  is 
not possible to cut all  Purkinje  cell  dendrites in the same 
plane, i.e. the dendrites intersect the cutting plane at every 
possible  angle.  Dendrites  lying  entirely  in  the  plane  of 
section  would  form  longer  bands of  degeneration than 
dendrites  that  intersected  the  plane  of  section  at  some 
angle. As a result, estimates of the number of degenerating 
Purkinje  cells,  rather  than  the  proportion  of  cerebellum 
covered by degeneration, would provide the only meaning- 
ful  measure for  inter-animal  comparisons of  degeneration 
produced by different  doses of ibogaine. 
Qualitatively  all but one animal could readily be placed 
in  one  of  two  categories by  estimating  the  number  of 
degenerating Purkinje  cells.  Animals  were  classified  as 
having extensive degeneration if  the tissue contained mul- 
tiple, bilaterally  symmetric bands of Fink-Heimer  or GFAP 
staining  in  both  the  anterior  and  posterior  lobes  of  the 
cerebellum. Animals  were classified as lacking  degenera- 
tion  if  the tissue contained two  or fewer  isolated lines of 
degeneration per section (i.e.  an average of  considerably 
less than one per lobule). 
Table  1 shows the classifications for all animals treated 
with  the different  doses of  ibogaine. From this  table it  is 
clear  that  doses of  100 mg/kg  ibogaine  (given  once or 
three times) produced degeneration in every animal tested. 
Table  1 
The occurrence of degeneration in all  animals examined 
Source  Tissue stin  No degeneration  Degeneration 
Animals  treated  with  saline 
Charles River  Fink-Heimer  2  0 
Animals  treated  with  40 mg/kg  ibogaine 
Charles River  Fink-Heimer  5  0 
GFAP  2  0 
Taconic  Farms  Fink Heimer  5  1 * 
GFAP  2  0 
Animals  treated  with  100 mg/kg  ibogaine 
Taconic  Farms  Fink-Heimer  0  2 
Animals  treated  with  3 X 100 mg/kg  ibogaine 
Charles River  Fink-Heimer  0  4 
GFAP  0  2 
Taconic  Farms  Fink-Heimer  0  5 
*  The degeneration in this animal was minimal  and confined  to lobules 6 
and 7. 
A  dose of  40  mg/kg,  on  the other hand, generally  only 
produced  the  same low  level  of  degeneration  as  s,iline 
treatment. Only  one of  the fifteen  animals treated v,  ,/,, 40 
mg/kg  ibogaine  displayed  evidence of  degeneration at a 
level  greater than that seen in  saline-treated animals. The 
amount of  degeneration in  this  animal  did  not,  however, 
come close to  that  seen with  high  doses of  ibogaine. In 
particular,  the degeneration consisted only  of isolated lines 
of  silver  grains scattered across lobules 6 and 7. 
Table  I  further  shows that in  animals  treated with  40 
mg/kg,  GFAP  staining  revealed no  greater incidence of 
responses  to ibogaine than did Fink-Heimer  staining. Thus, 
40  mg/kg  ibogaine  appears to  have little  or  no  adverse 
effect  on the cerebellum,  for  either of  the staining  proce- 
dures tested. 
4. Discussion 
This  study confirms  the observations of  O’Hearn  et al. 
and  O’Hearn  and  Molliver  [19,20]  that  high  doses of 
ibogaine produce degeneration of cerebellar Purkinje  cells. 
It  further  extends these observations by  showing  that de- 
generation (1) occurs in female as well  as in male rats; (2) 
does not  differ  across animals  purchased from  diffc’  nt 
suppliers;  and (3)  consistently  occurs in  intermediate  and 
lateral portions of the cerebellum, as well  as in the vermis. 
The specific  groups of Purkinje  cells that degenerate  in 
response to high  doses of  ibogaine varied  markedly  from 
animal  to animal.  In  Fig.  2, for  instance, the area around 
the  midline  of  one  animal  (Ib21)  contained  numerous 
bands of  degeneration whereas the same area in  the other 
animal (Ib2)  contained none. Similarly,  the ‘anti-addict:  2’ 
properties of ibogaine display marked intersubject variabil- 
ity  [9]. 
Despite the lack  of  a stereotyped response across ani- 
mals, certain cerebellar lobules preferentially  responded to 
high  doses of  ibogaine.  In  the anterior  lobe,  for  instance, 
degeneration occurred always in lobules 5 and 6, never in 
lobules  1 and 2, and occasionally in lobules 3 and 4. As in 
most species, the rat  anterior  lobe displays  a topograpi8  c 
organization:  Purkinje  cells  responsive to  stimulation  of 
the forelimb  and face are concentrated in  the vermis  and 
intermediate  portions  of  lobules  5  and  6;  Purkinje  cells 
responsive  to  stimulation  of  the  hindlimb,  on  the  other 
hand, extend from  lobules 2 to 6 [16]. As a result, ibogaine 
should have the most  profound  impact  on  movements  of 
the head and upper extremity.  During  the first  hour follow- 
ing  administration  of  ibogaine, rats and mice  consistenti, 
display  tremor  (e.g. [25]); a recent study found that this 
tremor preferentially involves the head and upper extrem- 
ity [4]. The nature of any longer-term deficits  produced by 
ibogaine toxicity  is not known.  Casual examination  of  the 
animals in  the present study given high  doses of  ibogaine 
revealed no gross motor deficiencies on the day they were lily  only 
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sacrificed. The results of this study suggest, however, that 
any evaluation  of  the possible long-term  toxic  effects  of 
ibogaine should  look  for  subtle motor  deficits  in  move- 
ments of the head or upper extremity rather than irregulari- 
ties in gait. 
High  doses of  ibogaine readily  produced degeneration 
;F  cerebellar Purkinje cells. In marked contrast, a low dose 
vt’ ibogaine failed to produce, in female rats, either degen- 
eration of  cerebellar  Purkinje  cells  or  responses in  glial 
cells  beyond  those  in  saline-treated animals.  Male  rats 
were  not  included  in  the  present  study.  The  fact  that 
female rats are more sensitive to the behavioral effects of 
ibogaine  than  males  [22],  however,  suggests that  males 
would be even less likely  to display  toxic  responses. For 
;  :her  gender,  the  low  dose  of  ibogaine  does  display 
,anti-addictive’  properties  [2,9,10].  Thus,  it  appears that 
alteration of  addictive  behavior  by  ibogaine  does not  re- 
quire degeneration of cerebellar Purkinje cells. 
Recent  work  shows  that  18-methoxycoronaridine,  an 
iboga alkaloid congener, has ‘anti-addictive’  properties but 
does not  cause Purkinje  cell  degeneration, even at  high 
doses [8].  Unlike  ibogaine,  18-methoxycoronaridine  does 
1  cause  tremor [8]. Moreover, compounds such as harma- 
line  readily  produce  both  tremor  [25]  and  Purkinje  cell 
degeneration [20]  but  have no long-term  impact  on  mor- 
phine or cocaine self-administration [9]. These data support 
.a growing  body  of  evidence [9]  indicating  that  although 
ibogaine and related compounds can produce degeneration 
in the cerebellum, this degeneration reflects their tremori- 
genie  rather  than  their  ‘anti-addictive’  properties.  The 
mars result, at least in part, from synchronous activation 
of  neurons in  the inferior  olive  [l].  It  appears that  only 
when activation  of  the inferior  olive  reaches extreme lev- 
els, causing vigorous  tremors [19], does loss of  cerebellar 
Purkinje cells occur. The level of activation  of the inferior 
olive and cerebellum appears,  however, to have no bearing 
on the ability  of  ibogaine to influence  addictive  behavior. 
This suggests that, in contrast to the proposal of  O’Heam 
&..!ci  Molliver  [23],  the cerebellum does not play  a role  in 
addiction. 
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